|
Ethyl 4-(3-(2-furyl)-4-(4-hydroxyphenyl)-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)benzoate |
|
Vibrio |
Stress survival |
Preclinical (in vitro) |
Stanbery L, et al. 2017. Drug Des Devel Ther |
|
2-chloro-4-{5-[(E)-2-(4,6-dihydroxy-5-nitropyrimidin-2-yl)ethenyl]furan-2-yl}benzoic acid |
Depiction based on curated SMILES
O
NH
O
_
O
O
+
N
HO
N
O
Cl
OH
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Eriksson J, et al. 2012. Adv Exp Med Biol |
|
2-chloro-5-[5-[(Z)-[1-(furan-2-ylmethyl)-4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene]methyl]furan-2-yl]benzoic acid |
Depiction based on curated SMILES
O
O
O
N
S
N
H
O
O
Cl
OH
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Eriksson J, et al. 2012. Adv Exp Med Biol |
|
2-hydroxy-5-[5-[(E)-3-oxo-3-[4-(3-phenyl-1,2,4-thiadiazol-5-yl)-1,4-diazepan-1-yl]prop-1-enyl]furan-2-yl]benzoic acid |
Depiction based on curated SMILES
OH
O
HO
N
N
S
N
N
O
O
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Leone M, et al. 2010. Chem Biol Drug Des |
|
4-[5-(Hexahydro-4,6-dioxo-2-thioxopyrimidine-5-ylidenemethyl)-2-furanyl]-2-hydroxybenzoic acid |
Depiction based on curated SMILES
OH
S
H
N
O
O
OH
O
H
O
N
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Tautz L, et al. 2005. J Biol Chem |
|
(Z)-5-(5-((2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)-2-hydroxybenzoic acid |
Depiction based on curated SMILES
S
O
OH
HO
O
O
O
HN
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Tautz L, et al. 2005. J Biol Chem |
|
5-[5-(2,3-Dihydro-6,7-dimethyl-3-oxothiazolo[3,2-a]benzimidazole-2-ylidenemethyl)-2-furanyl]-2-hydroxybenzoic acid |
Depiction based on curated SMILES
N
S
HO
O
OH
O
CH
3
O
N
CH
3
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Tautz L, et al. 2005. J Biol Chem |
|
5-[5-[(Z)-[[6-(4-fluoroanilino)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl]hydrazinylidene]methyl]furan-2-yl]-2-hydroxybenzoic acid |
Depiction based on curated SMILES
O
N
HO
O
OH
F
NH
N
N
O
N
N
NH
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
5-({(E)-[2-(4-chlorophenyl)-5-oxo-1,3-oxazol-4(5H)-ylidene]methyl}amino)-2-hydroxybenzoic acid |
Depiction based on curated SMILES
HO
O
O
Cl
O
N
N
H
HO
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
| | |
| | |
| | |